Johns Hopkins ABX Guide
Levofloxacin
Levofloxacin is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please sign in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Acute bacterial exacerbations of chronic bronchitis (ABECB)
- Acute bacterial sinusitis
- Uncomplicated urinary tract infections
- Note: use of levofloxacin for these indications should be avoided due recent FDA warning (Boxed warning) regarding serious side effects and potentially permanent (tendonitis and tendon rapture, peripheral neuropathy and CNS side effects). FDA safety warning regarding Fluoroquinolone use
- Pneumonia: community-acquired pneumonia and nosocomial pneumonia
- Inhalational anthrax (post-exposure)
- Uncomplicated and complicated skin and soft tissue infections (not MRSA)
- Complicated urinary tract infections
- Acute pyelonephritis
- Bacterial conjunctivitis (Quixin 0.5% opthalmic drops)
- Treatment of corneal ulcer (1.5% ophthalmic solution)
- Chronic bacterial prostatitis
NON-FDA
NON-FDA
- Treatment of M. tuberculosis including MDR and XDR-TB (in combination with other agents)
- Treatment of MAI and other non-TB mycobacterial infections (in combination with other agents)
- Alternative therapy for treatment of S. pneumoniae and H. influenzae meningitis in patients who have severe penicillin allergies.
- Bone and joint infections
- Intra-abdominal infections in combination with metronidazole
- H. pylori in combination with other agents
- Prophylaxis in neutropenic patients
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
INDICATIONS
FDA
FDA
- Acute bacterial exacerbations of chronic bronchitis (ABECB)
- Acute bacterial sinusitis
- Uncomplicated urinary tract infections
- Note: use of levofloxacin for these indications should be avoided due recent FDA warning (Boxed warning) regarding serious side effects and potentially permanent (tendonitis and tendon rapture, peripheral neuropathy and CNS side effects). FDA safety warning regarding Fluoroquinolone use
- Pneumonia: community-acquired pneumonia and nosocomial pneumonia
- Inhalational anthrax (post-exposure)
- Uncomplicated and complicated skin and soft tissue infections (not MRSA)
- Complicated urinary tract infections
- Acute pyelonephritis
- Bacterial conjunctivitis (Quixin 0.5% opthalmic drops)
- Treatment of corneal ulcer (1.5% ophthalmic solution)
- Chronic bacterial prostatitis
NON-FDA
NON-FDA
- Treatment of M. tuberculosis including MDR and XDR-TB (in combination with other agents)
- Treatment of MAI and other non-TB mycobacterial infections (in combination with other agents)
- Alternative therapy for treatment of S. pneumoniae and H. influenzae meningitis in patients who have severe penicillin allergies.
- Bone and joint infections
- Intra-abdominal infections in combination with metronidazole
- H. pylori in combination with other agents
- Prophylaxis in neutropenic patients
There's more to see -- the rest of this entry is available only to subscribers.
Last updated: July 2, 2017
Citation
Avdic, Edina, and Paul A Pham. "Levofloxacin." Johns Hopkins ABX Guide, The Johns Hopkins University, 2017. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540312/all/Levofloxacin.
Avdic E, Pham PA. Levofloxacin. Johns Hopkins ABX Guide. The Johns Hopkins University; 2017. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540312/all/Levofloxacin. Accessed April 3, 2020.
Avdic, E., & Pham, P. A. (2017). Levofloxacin. In Johns Hopkins ABX Guide. The Johns Hopkins University. Retrieved April 03, 2020, from https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540312/all/Levofloxacin
Avdic E, Pham PA. Levofloxacin [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2017. [cited 2020 April 03]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540312/all/Levofloxacin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Levofloxacin
ID - 540312
A1 - Avdic,Edina,Pharm.D.
AU - Pham,Paul,Pharm.D.
Y1 - 2017/07/02/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540312/all/Levofloxacin
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -